| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 996.60M | 1.10B | 1.11B | 1.11B | 950.50M |
| Gross Profit | 87.50M | 813.20M | 120.80M | 244.70M | 207.10M |
| EBITDA | 130.50M | 150.00M | 138.60M | 188.10M | 156.30M |
| Net Income | 21.10M | 50.30M | 47.30M | 88.00M | 73.80M |
Balance Sheet | |||||
| Total Assets | 984.80M | 1.08B | 1.02B | 1.03B | 925.40M |
| Cash, Cash Equivalents and Short-Term Investments | 126.50M | 118.60M | 124.50M | 117.70M | 127.30M |
| Total Debt | 360.70M | 393.70M | 356.80M | 318.10M | 223.80M |
| Total Liabilities | 635.90M | 687.80M | 626.10M | 602.30M | 575.80M |
| Stockholders Equity | 316.60M | 353.70M | 360.30M | 389.00M | 310.60M |
Cash Flow | |||||
| Free Cash Flow | 53.50M | 17.20M | 18.10M | -37.40M | 74.60M |
| Operating Cash Flow | 120.60M | 113.30M | 78.50M | 20.60M | 106.20M |
| Investing Cash Flow | -55.00M | -86.00M | -60.20M | -57.00M | -13.90M |
| Financing Cash Flow | -99.50M | -33.00M | -2.00M | 23.40M | -112.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £916.17M | 15.43 | 33.12% | 1.01% | 24.42% | 103.25% | |
71 Outperform | £6.31B | 20.02 | 24.91% | 1.29% | -0.32% | -3.96% | |
67 Neutral | £2.62B | 23.57 | 20.10% | 2.04% | 1.93% | -15.07% | |
64 Neutral | £7.22B | 15.58 | 13.46% | 1.93% | -6.93% | 18.57% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | £564.85M | 28.89 | 8.04% | 4.87% | -7.30% | -59.71% | |
62 Neutral | £1.08B | 22.48 | 8.58% | 3.30% | -6.95% | -52.08% |